| PedBot Ankle Rehablitation (NCT05825508) | Children's National Research Institute | 2022-07-28 |
| A Study of Tumor Imaging With Multispectral Optoacoustic Tomography (NCT05488483) | Memorial Sloan Kettering Cancer Center | 2022-07-27 |
| Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer (NCT05353439) | National Cancer Institute (NCI) | 2022-07-27 |
| A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study (NCT05899049) | Merck Sharp & Dohme LLC | 2022-07-27 |
| Neurostimulation to Improve NOWS Outcomes (NCT05129020) | Spark Biomedical, Inc. | 2022-07-27 |
| A Study of Observation and Follow-up in People With Basal Cell Carcinoma (NCT05473507) | Memorial Sloan Kettering Cancer Center | 2022-07-27 |
| HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma (NCT04903080) | Children's Oncology Group | 2022-07-27 |
| Thoracic Neuromodulation for Diabetic Gastroparesis (NCT05273788) | Medical University of South Carolina | 2022-07-27 |
| Addiction Intervention in Liver Transplantation Candidates (NCT05322226) | University Hospital, Montpellier | 2022-07-27 |
| Advanced or Recurrent Solid Tumors Treated With SHetA2 (NCT04928508) | University of Oklahoma | 2022-07-27 |
| Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above (NCT05404945) | University of Virginia | 2022-07-26 |
| Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (NCT05172258) | National Cancer Institute (NCI) | 2022-07-26 |
| Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy (NCT04989504) | Alliance for Clinical Trials in Oncology | 2022-07-26 |
| A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors (NCT05502393) | Shanghai Junshi Bioscience Co., Ltd. | 2022-07-26 |
| Corticosteroid Effect on Achalasia Variant EGJOO (NCT06588348) | Baylor Research Institute | 2022-07-26 |
| A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study (NCT05613569) | Kolon Life Science | 2022-07-26 |
| Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease (NCT05421728) | University of Colorado, Denver | 2022-07-26 |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (NCT05382286) | Gilead Sciences | 2022-07-25 |
| A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. (NCT05335993) | CanariaBio Inc. | 2022-07-25 |
| Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy (NCT05352828) | Tessa Therapeutics | 2022-07-25 |
| Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma (NCT05315258) | University of Oxford | 2022-07-25 |
| Cold Acclimation as a Modulator of Brown Adipose Tissue Function in Adults With Obesity (NCT05468151) | Turku University Hospital | 2022-07-25 |
| Identification of Neuroprognostic Factors for Out-of-hospital Cardiopulmonary Arrest (MIRA29) (NCT06569134) | University Hospital, Brest | 2022-07-24 |
| A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease (NCT05242471) | Janssen Research & Development, LLC | 2022-07-22 |
| LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05321420) | PureTech | 2022-07-22 |
| System Dynamics Model for Acute Non-contact Lower Extremity Injuries Prediction (NCT05425303) | University of Patras | 2022-07-22 |
| V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071) (NCT05450705) | Merck Sharp & Dohme LLC | 2022-07-22 |
| Prospective Observational Study for Breast Microcalcifications' Classification With Artificial Intelligence Techniques (NCT05767424) | Istituti Clinici Scientifici Maugeri SpA | 2022-07-22 |
| Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (NCT05800951) | Henry Ford Health System | 2022-07-22 |
| Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma (NCT05496686) | Modulation Therapeutics, Inc. | 2022-07-21 |
| A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies (NCT05032040) | Xencor, Inc. | 2022-07-21 |
| Strategies for Kidney Outcomes Prevention and Evaluation - The SKOPE Study (NCT05295368) | Duke-NUS Graduate Medical School | 2022-07-21 |
| A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) (NCT05458297) | Merck Sharp & Dohme LLC | 2022-07-21 |
| Timing of Damage Control Orthopedic Surgery (NCT05785143) | China Medical University Hospital | 2022-07-20 |
| Community Driven Substance Use Recovery for High Opioid Overdose Areas (NCT05260047) | Yale University | 2022-07-20 |
| Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors (NCT05334329) | University of California, Irvine | 2022-07-20 |
| STAR-LIFE: a Post-market Registry on MINIject (NCT05269680) | iSTAR Medical | 2022-07-20 |
| Assessing Brain Metabolism Using MRS With Deuterated Glucose (NCT06594315) | University of California, San Francisco | 2022-07-20 |
| A Study of MT-0551 in Patients With Systemic Sclerosis (NCT05198557) | Tanabe Pharma Corporation | 2022-07-20 |
| Promoting Resilience in Stroke Survivor-carepartner Dyads (ReStoreD) (NCT04845542) | University of Utah | 2022-07-20 |
| SP Thoracic IDE Study (NCT05150210) | Intuitive Surgical | 2022-07-20 |
| Early Predictors for Neurological Outcome After Traumatic Spinal Cord Injury (NCT07210879) | BG Unfallklinik Murnau | 2022-07-20 |
| Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (NCT05382299) | Gilead Sciences | 2022-07-20 |
| Evaluation of the Effect of Para-sternal Block on Postoperative Respiratory Function After Cardiac Sternotomy Surgery (NCT05515809) | Centre Hospitalier Universitaire, Amiens | 2022-07-19 |
| Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial (NCT05361421) | Yonsei University | 2022-07-19 |
| Blood Vessel Anatomy and Blood Flow Regulation (NCT05396287) | University of Wisconsin, Madison | 2022-07-19 |
| Predictors Of Cognitive Decline Using Digital Devices (NCT07051408) | University College, London | 2022-07-19 |
| Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation (NCT05308446) | National Cancer Institute (NCI) | 2022-07-19 |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT05139004) | City of Hope Medical Center | 2022-07-19 |
| Hereditary Cerebral Small Vessel Diseases Registry-Trial Ready Cohort (NCT06512376) | Beijing Tiantan Hospital | 2022-07-19 |
| Prognostic's Factors of Head and Neck Paragangliomas Evolution (NCT05233878) | Hospices Civils de Lyon | 2022-07-19 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM (NCT07150091) | GlaxoSmithKline | 2022-07-19 |
| First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors (NCT05438329) | DualityBio Inc. | 2022-07-19 |
| Xenon MRI and Progressive ILD (NCT05241275) | Duke University | 2022-07-19 |
| Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients (NCT05222555) | Incyte Corporation | 2022-07-19 |
| A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors (NCT05385484) | University of Pennsylvania | 2022-07-18 |
| Hand-Arm Bimanual Intensive Therapy in Virtual Reality Versus Standard Hand-Arm Bimanual Intensive Therapy (NCT05867368) | University of Nebraska | 2022-07-18 |
| Assess Safety and Efficacy of VAD044 in HHT Patients (NCT05406362) | Vaderis Therapeutics AG | 2022-07-18 |
| Segmental Muscle Vibration on Pain in Patients With Primary Cervical Dystonia (NCT06748846) | Fondazione Don Carlo Gnocchi ETS | 2022-07-18 |
| Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms (NCT05455294) | Jacqueline Garcia, MD | 2022-07-18 |
| A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) (NCT05296798) | Hoffmann-La Roche | 2022-07-18 |
| Financial Toxicity in Breast Cancer Surgery (NCT05104632) | McMaster University | 2022-07-18 |
| PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT05340270) | Guangxi Medical University | 2022-07-15 |
| The TRICURE First in Human Trial (NCT05126030) | TRiCares | 2022-07-15 |
| Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy (NCT05506254) | Alexion Pharmaceuticals, Inc. | 2022-07-15 |
| Effect of a FLUid Bolus or a Low Dose VAsopressor Infusion on Cardiovascular Collapse Among Critically Ill Adults Undergoing Tracheal Intubation. (NCT05318066) | Tata Memorial Centre | 2022-07-15 |
| Preventing Cognitive Decline with Metformin (NCT04511416) | Garvan Institute of Medical Research | 2022-07-15 |
| Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple Sclerosis (NCT05469568) | Brno University Hospital | 2022-07-15 |
| Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) (NCT05453435) | Sun Yat-sen University | 2022-07-15 |
| Descemet Endothelial Thickness Comparison Trial I (NCT05289661) | Stanford University | 2022-07-15 |
| Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1) (NCT05396885) | Kite, A Gilead Company | 2022-07-15 |
| Personalized Ultrasonic Brain Stimulation for Depression (NCT05301036) | University of Utah | 2022-07-15 |
| Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis (NCT05126277) | Novartis Pharmaceuticals | 2022-07-14 |
| Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (NCT05340374) | Peter MacCallum Cancer Centre, Australia | 2022-07-14 |
| Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy (NCT05469009) | Ali Rezai | 2022-07-14 |
| A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) (NCT05406401) | Merck Sharp & Dohme LLC | 2022-07-14 |
| Effectiveness of a Dyadic Pain Management Program for Community-dwelling Older Adults with Chronic Pain (NCT05056623) | Hong Kong Metropolitan University | 2022-07-14 |
| My Baby Biome: Infant Stool Samples for Microbiome Health (MBB) (NCT05472688) | Persephone Biosciences | 2022-07-14 |
| Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma (NCT05970757) | Erasmus Medical Center | 2022-07-14 |
| Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (NCT05183932) | Washington University School of Medicine | 2022-07-14 |
| A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis (NCT05526222) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2022-07-14 |
| Chinese American Cancer Survivors Writing Study (NCT05456100) | New York University | 2022-07-14 |
| Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma (NCT05352672) | Regeneron Pharmaceuticals | 2022-07-14 |
| Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study (NCT07008924) | University of Kansas Medical Center | 2022-07-14 |
| Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study (NCT05357469) | M.D. Anderson Cancer Center | 2022-07-14 |
| Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (NCT05263934) | GlaxoSmithKline | 2022-07-14 |
| A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab (NCT05142696) | Novartis Pharmaceuticals | 2022-07-13 |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients (NCT06390904) | Xiaojun Chen | 2022-07-13 |
| A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE) (NCT05392114) | Ionis Pharmaceuticals, Inc. | 2022-07-13 |
| A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC (NCT05246514) | AstraZeneca | 2022-07-13 |
| Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002) (NCT05233618) | Karen Ballen, MD | 2022-07-13 |
| Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer (NCT05130840) | Memorial Sloan Kettering Cancer Center | 2022-07-13 |
| Quantification and Repeatability of Magnetic Stimulation (NCT05302752) | Swiss Federal Institute of Technology | 2022-07-13 |
| A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies (NCT05362773) | MacroGenics | 2022-07-13 |
| Pembrolizumab in Muscle-invasive Bladder Cancer (NCT05406713) | Matthew Galsky | 2022-07-13 |
| INSPIRIS China PMCF Study (NCT05404880) | Edwards Lifesciences | 2022-07-13 |
| TMLI and Alemtuzumab for Treatment of Sickle Cell Disease (NCT05384756) | City of Hope Medical Center | 2022-07-13 |
| A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) (NCT05353647) | David Williams | 2022-07-12 |
| Leucine, mTOR and Athero (NCT05470218) | University of Missouri-Columbia | 2022-07-12 |
| ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence (NCT05301673) | King's College London | 2022-07-12 |